Roberts Luke B, Neves Joana F, Lee Dave C H, Valpione Sara, Tachó-Piñot Roser, Howard Jane K, Hepworth Matthew R, Lord Graham M
Lydia Becker Institute of Immunology and Inflammation, University of Manchester, M13 9PL, United Kingdom.
Centre for Host-Microbiome Interactions, King's College London, Great Maze Pond, London SE1 9RT, United Kingdom.
Mucosal Immunol. 2025 Feb;18(1):39-52. doi: 10.1016/j.mucimm.2024.09.001. Epub 2024 Sep 7.
The transcriptomic signatures that shape responses of innate lymphoid cells (ILCs) have been well characterised, however post-transcriptional mechanisms which regulate their development and activity remain poorly understood. We demonstrate that ILC groups of the intestinal lamina propria express mature forms of microRNA-142 (miR-142), an evolutionarily conserved microRNA family with several non-redundant regulatory roles within the immune system. Germline Mir142 deletion alters intestinal ILC compositions, resulting in the absence of T-bet populations and significant defects in the cellularity and phenotypes of ILC3 subsets including CCR6 LTi-like ILC3s. These effects were associated with decreased pathology in an innate-immune cell driven model of colitis. Furthermore, Mir142 mice demonstrate defective development of gut-associated lymphoid tissues, including a complete absence of mature Peyer's patches. Conditional deletion of Mir142 in ILC3s (Rorc) supported cell-intrinsic roles for these microRNAs in establishing or maintaining cellularity and functions of LTi-like ILC3s in intestinal associated tissues. RNAseq analysis revealed several target genes and biological pathways potentially regulated by miR-142 microRNAs in these cells. Finally, lack of Mir142 in ILC3 led to elevated IL-17A production. These data broaden our understanding of immune system roles of miR-142 microRNAs, identifying these molecules as critical post-transcriptional regulators of ILC3s and intestinal mucosal immunity.
塑造固有淋巴细胞(ILC)反应的转录组特征已得到充分表征,然而,调节其发育和活性的转录后机制仍知之甚少。我们证明,肠道固有层的ILC群体表达成熟形式的微小RNA-142(miR-142),这是一个在免疫系统中具有多种非冗余调节作用的进化保守的微小RNA家族。种系Mir142缺失会改变肠道ILC的组成,导致T-bet群体缺失以及ILC3亚群(包括CCR6 LTi样ILC3)的细胞数量和表型出现显著缺陷。这些效应与先天免疫细胞驱动的结肠炎模型中病理状况的减轻有关。此外,Mir142基因敲除小鼠表现出肠道相关淋巴组织发育缺陷,包括完全没有成熟的派尔集合淋巴结。在ILC3(Rorc)中条件性缺失Mir142支持了这些微小RNA在建立或维持肠道相关组织中LTi样ILC3的细胞数量和功能方面的细胞内在作用。RNA测序分析揭示了这些细胞中可能受miR-142微小RNA调控的几个靶基因和生物学途径。最后,ILC3中缺乏Mir142导致IL-17A产生增加。这些数据拓宽了我们对miR-142微小RNA在免疫系统中作用的理解,将这些分子确定为ILC3和肠道黏膜免疫的关键转录后调节因子。